Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127061822 | 12706182 | 2 | F | 20160429 | 20160901 | 20160901 | PER | US-JAZZ-2016-US-008252 | JAZZ | 0.00 | M | Y | 0.00000 | 20160901 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127061822 | 12706182 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 127061822 | 12706182 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 127061822 | 12706182 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | 21196 | 3.75 | G | ORAL SOLUTION | |||||||
| 127061822 | 12706182 | 4 | SS | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127061822 | 12706182 | 5 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 6 | C | Atorvastatin | ATORVASTATIN | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 7 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 8 | C | FINASTERIDE. | FINASTERIDE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 10 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 11 | C | ALLEGRA ALLERGY | FEXOFENADINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 12 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 13 | C | Apple cider vinegar | APPLE CIDER VINEGAR | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 14 | C | CLARITIN | LORATADINE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 15 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 16 | C | KETOCONAZOLE. | KETOCONAZOLE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 17 | C | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 18 | C | SUDAFED | PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 19 | C | TRETINOIN. | TRETINOIN | 1 | U | 0 | |||||||||||
| 127061822 | 12706182 | 20 | C | TYLENOL 8 HR | ACETAMINOPHEN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127061822 | 12706182 | 1 | Narcolepsy |
| 127061822 | 12706182 | 2 | Cataplexy |
| 127061822 | 12706182 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127061822 | 12706182 | Dizziness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127061822 | 12706182 | 1 | 201602 | 201602 | 0 | |
| 127061822 | 12706182 | 2 | 201602 | 201602 | 0 | |
| 127061822 | 12706182 | 3 | 201602 | 0 |